ARCHIVES

Remaining DCT Recompetitions

This article is from The Cancer Letter archive.

Vol. 06 No. 44 | November 7, 1980

Download PDF Visit The Full Archive

Related Articles

In Brief: Barry Pierce New DCCP Chairman; Adamson Seeks Ads For Chemical, Biological Carcinogenesis

June 17, 1983

Motesanib Does Not Improve OS; Study Doesn’t Meet Primary Endpoint

April 29, 2011

Hellman, Suit Awarded ASTRO’s Gold Medals

October 26, 1990

Whole Brain Radiation Raises Risk Of Memory Problems

September 26, 2008

Yarbro Leaves Centers Program With Pitch for More Money for Core Grants, Community Outreach, Control

July 18, 1975

Phase III Tecemotide Trial Fails OS Endpoint; Second Trial Planned After Subgroup Analysis

December 27, 2013